Calliditas Therapeutics (CALT)
(Delayed Data from NSDQ)
$38.26 USD
-0.25 (-0.64%)
Updated Jul 24, 2024 03:52 PM ET
After-Market: $38.50 +0.25 (0.64%) 6:28 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/15/24 |
---|---|
Current Quarter | -0.25 |
EPS Last Quarter | -0.88 |
Last EPS Surprise | -528.57% |
ABR | 3.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.86 |
Next Year | 3.64 |
EPS (TTM) | -1.85 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 42.89M | 47.89M | 175.20M | 336.68M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 45.47M | 48.70M | 177.69M | 443.01M |
Low Estimate | 41.39M | 47.06M | 171.58M | 276.29M |
Year ago Sales | 25.60M | 27.25M | 113.63M | 175.20M |
Year over Year Growth Est. | 67.55% | 75.74% | 54.19% | 92.17% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.25 | -0.06 | -0.86 | 3.64 |
# of Estimates | 4 | 4 | 4 | 3 |
Most Recent Consensus | 0.03 | 0.07 | -0.47 | 1.62 |
High Estimate | 0.03 | 0.14 | -0.44 | 6.38 |
Low Estimate | -0.58 | -0.36 | -1.56 | 1.62 |
Year ago EPS | -0.33 | -0.58 | -1.64 | -0.86 |
Year over Year Growth Est. | 24.24% | 89.66% | 47.56% | 522.67% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.25 | -0.06 | -0.86 | 3.64 |
7 Days Ago | -0.25 | -0.06 | -0.86 | 3.64 |
30 Days Ago | -0.25 | -0.06 | -0.86 | 3.64 |
60 Days Ago | -0.25 | -0.06 | -0.86 | 3.40 |
90 Days Ago | -0.05 | 0.14 | 0.30 | 3.45 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.25 | -0.06 | -0.86 | 3.64 |
Zacks Consensus Estimate | -0.25 | -0.06 | -0.86 | 3.64 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.88 | -0.06 | -0.58 | -0.33 | NA |
Estimate | -0.14 | -0.10 | -0.22 | -0.25 | NA |
Difference | -0.74 | 0.04 | -0.36 | -0.08 | -0.29 |
Surprise | -528.57% | 40.00% | -163.64% | -32.00% | -171.05% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more